Plasma Cytochrome c as Biomarker of Traumatic Injury and Predictor of Outcome
Sponsor: Rosalind Franklin University of Medicine and Science
Listed as NCT02440373, this observational or N/A phase trial focuses on Accident and Blunt Injury and remains completed. Sponsored by Rosalind Franklin University of Medicine and Science, it has been updated 12 times since 2014, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
12 versions recorded-
Nov 2024 — Present [monthly]
Completed
-
Sep 2024 — Nov 2024 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
▶ Show 7 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Completed
-
Jun 2018 — Nov 2020 [monthly]
Completed
-
May 2018 — Jun 2018 [monthly]
Completed
-
Apr 2018 — May 2018 [monthly]
Completed
Status: Active Not Recruiting → Completed · Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Active Not Recruiting NA
-
Feb 2017 — Aug 2017 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
Mar 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Rosalind Franklin University of Medicine and Science
- Wake Forest University Health Sciences
For direct contact, visit the study record on ClinicalTrials.gov .